Primary tumor radiotherapy for metastatic hormone-sensitive prostate cancer
Methodological advances with new framework adaptive meta-analysis
0 COMENTÁRIOS
Methodological advances with new framework adaptive meta-analysis
0 COMENTÁRIOS
What is the right choice?
1 COMENTÁRIOS
Still a double standard evaluation
0 COMENTÁRIOS
Dealing with fast therapeutic metamorphosis
0 COMENTÁRIOS